[go: up one dir, main page]

GB202016931D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB202016931D0
GB202016931D0 GBGB2016931.4A GB202016931A GB202016931D0 GB 202016931 D0 GB202016931 D0 GB 202016931D0 GB 202016931 A GB202016931 A GB 202016931A GB 202016931 D0 GB202016931 D0 GB 202016931D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2016931.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
C4X Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C4X Discovery Ltd filed Critical C4X Discovery Ltd
Priority to GBGB2016931.4A priority Critical patent/GB202016931D0/en
Publication of GB202016931D0 publication Critical patent/GB202016931D0/en
Priority to EP21728074.2A priority patent/EP4157828A1/en
Priority to BR112022023983A priority patent/BR112022023983A2/en
Priority to TW110118784A priority patent/TW202210466A/en
Priority to US17/926,868 priority patent/US20230286943A1/en
Priority to AU2021281379A priority patent/AU2021281379A1/en
Priority to PCT/EP2021/063937 priority patent/WO2021239745A1/en
Priority to MX2022014924A priority patent/MX2022014924A/en
Priority to IL298578A priority patent/IL298578A/en
Priority to KR1020227045476A priority patent/KR20230016219A/en
Priority to PH1/2022/553019A priority patent/PH12022553019A1/en
Priority to JP2022572525A priority patent/JP7787827B2/en
Priority to CA3180079A priority patent/CA3180079A1/en
Priority to CONC2022/0016899A priority patent/CO2022016899A2/en
Ceased legal-status Critical Current

Links

GBGB2016931.4A 2020-05-27 2020-10-26 Therapeutic compounds Ceased GB202016931D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB2016931.4A GB202016931D0 (en) 2020-10-26 2020-10-26 Therapeutic compounds
CA3180079A CA3180079A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
PCT/EP2021/063937 WO2021239745A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
IL298578A IL298578A (en) 2020-05-27 2021-05-25 Il-17a modulators
TW110118784A TW202210466A (en) 2020-05-27 2021-05-25 Therapeutic compounds
US17/926,868 US20230286943A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
AU2021281379A AU2021281379A1 (en) 2020-05-27 2021-05-25 IL-17A modulators
EP21728074.2A EP4157828A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
MX2022014924A MX2022014924A (en) 2020-05-27 2021-05-25 IL-17A MODULATORS.
BR112022023983A BR112022023983A2 (en) 2020-05-27 2021-05-25 THERAPEUTIC COMPOUNDS
KR1020227045476A KR20230016219A (en) 2020-05-27 2021-05-25 IL-17A modulator
PH1/2022/553019A PH12022553019A1 (en) 2020-05-27 2021-05-25 Il-17a modulators
JP2022572525A JP7787827B2 (en) 2020-05-27 2021-05-25 IL-17A modulators
CONC2022/0016899A CO2022016899A2 (en) 2020-05-27 2022-11-25 il-17a modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2016931.4A GB202016931D0 (en) 2020-10-26 2020-10-26 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB202016931D0 true GB202016931D0 (en) 2020-12-09

Family

ID=73726995

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2016931.4A Ceased GB202016931D0 (en) 2020-05-27 2020-10-26 Therapeutic compounds

Country Status (1)

Country Link
GB (1) GB202016931D0 (en)

Similar Documents

Publication Publication Date Title
GB202005852D0 (en) Therapeutic compounds
GB202005863D0 (en) Therapeutic compounds
GB202001980D0 (en) Therapeutic mentods
GB201908885D0 (en) Therapeutic compounds
GB202103640D0 (en) Therapeutic compounds
GB202103164D0 (en) Therapy
GB202006960D0 (en) Therapeutic
GB202002639D0 (en) Therapy
GB202103642D0 (en) Therapeutic compounds
GB202111035D0 (en) Therapy
GB202108303D0 (en) Therapy
GB202110728D0 (en) Therapeutic compounds
GB202101577D0 (en) Therapeutic compounds
GB202101574D0 (en) Therapeutic compounds
GB202016931D0 (en) Therapeutic compounds
GB202016934D0 (en) Therapeutic compounds
GB202012670D0 (en) Therapeutic compounds
GB202007931D0 (en) Therapeutic compounds
GB202007925D0 (en) Therapeutic compounds
GB202005846D0 (en) Therapeutic compounds
GB202005848D0 (en) Therapeutic compounds
IL321362A (en) Therapeutic compounds
GB202302445D0 (en) Therapeutic compounds
GB202217955D0 (en) Therapeutic compounds
GB202207050D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: SANOFI

Free format text: FORMER OWNER: C4X DISCOVERY LIMITED

AT Applications terminated before publication under section 16(1)